Saul Ewing Advises Client Supernus Pharmaceuticals in Merger With Indivior Pharmaceuticals Inc.
August 04, 2026
August 04, 2026
PHILADELPHIA, Pennsylvania, Aug. 4 -- Saul Ewing, a law firm, issued the following news release:
* * *
Saul Ewing Advises Client Supernus Pharmaceuticals in Merger with Indivior Pharmaceuticals, Inc.
Saul Ewing served as legal counsel to Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) in connection with its definitive agreement to merge with Indivior Pharmaceuticals, Inc. (Nasdaq: INDV). The tax-free, all-stock merger of equals will combine the two companies . . .
* * *
Saul Ewing Advises Client Supernus Pharmaceuticals in Merger with Indivior Pharmaceuticals, Inc.
Saul Ewing served as legal counsel to Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) in connection with its definitive agreement to merge with Indivior Pharmaceuticals, Inc. (Nasdaq: INDV). The tax-free, all-stock merger of equals will combine the two companies . . .